touchPODCAST

Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting

touchEXPERT OPINIONS for touchONCOLOGY

Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role of the multidisciplinary team in implementing this treatment modality.

The experts

• Dr Laura Mertens, Netherlands Cancer Institute, Amsterdam, The Netherlands
• Prof. Thomas Powles, Barts Cancer Centre, London, UK
• Ms Lindsay Diamond, Icahn School of Medicine at Mount Sinai, New York, NY, USA

This touchPODCAST is for healthcare professionals outside of the UK only.

This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. 

For further information visit our website: 

www.touchONCOLOGY.com 

Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY

touchEXPERT OPINIONS for touchDERMATOLOGY

Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.

The experts

• Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
• Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
• Dr Teresa Amaral, Tübingen University, Tübingen, Germany

This touchPODCAST is for healthcare professionals outside of the UK only

This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. 

For further information visit our website: 
https://touchdermaime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma

Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY

touchEXPERT OPINIONS for touchONCOLOGY 

Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions.

The experts

• Dr Tina J Hieken, Mayo Clinic, Rochester, MN, USA
• Prof. Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
• Dr Teresa Amaral, Tübingen University, Tübingen, Germany

This touchPODCAST is for healthcare professionals outside of the UK only

This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. 

For further information visit our website: 
https://touchoncologyime.org/navigating_treatment_choices_in_high-risk_early-stage_melanoma

Advances in IOL technology and power calculations: Updates and innovations from 2024

touchFOCUS for touchOPHTHALMOLOGY

Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens power calculation, including how the use of artificial intelligence may help to improve accuracy, and provides an update on the latest advances in intraocular lens technology.

The expert

• Dr John Ladas, Maryland Eye Consultants & Surgeons, Silver Spring, MD, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc. and Carl Zeiss Meditec, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchophthalmology.com/

Supporting healing in epidermolysis bullosa: Innovations and new directions for care

touchFOCUS for touchDERMATOLOGY

Listen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, including its pathophysiology and clinical manifestations. In addition, she responds to questions on the role of new and emerging topical therapies for epidermolysis bullosa in patient care, with a focus on a multidisciplinary team approach.

The expert:

• Prof. Amy Paller - Northwestern University Feinberg School of Medicine, Chicago, IL, USA
  

This touchPODCAST is for HCPs outside the UK. 

This activity is funded by an independent medical education grant from Chiesi USA Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchDERMA.com

Primary biliary cholangitis: Appraising the changing therapeutic landscape

touchEXPERT OPINIONS for touchIMMUNOLOGY

Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis. 

The expert

Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.org/Primary-biliary-cholangitis-therapeutic-landscape

Primary biliary cholangitis: Appraising the changing therapeutic landscape

touchEXPERT OPINIONS for touchENDOCRINOLOGY

Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis. 

The expert

Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Gilead Sciences Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:  https://touchendocrinologyime.org/primary-biliary-cholangitis-therapeutic-landscape

touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

touchMDT for touchONCOLOGY

Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.

The multidisciplinary team

• Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center,  Houston, TX, USA
• Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine,  Baltimore, MD, USA
• Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
• Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
• Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

This touchPODCAST is for HCPs outside the UK.

This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchONCOLOGY.com 

touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3

touchMDT for touchONCOLOGY

Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.

The multidisciplinary team

• Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center,  Houston, TX, USA
• Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine,  Baltimore, MD, USA
• Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
• Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
• Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

This touchPODCAST is for HCPs outside the UK.

This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchONCOLOGY.com 

touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4

touchMDT for touchRESPIRATORY

Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations.

The multidisciplinary team

• Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center,  Houston, TX, USA
• Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Medicine,  Baltimore, MD, USA
• Clinical oncology pharmacist: Dr Sandra Cuellar, University of Illinois, Chicago, IL, USA
• Oncology nurse practitioner: Ms Stephanie McDonald, Dana-Farber Cancer Institute, Boston, MA, USA
• Molecular pathologist: Prof. Albrecht Stenzinger, University Hospital Heidelberg, Germany

This touchPODCAST is for HCPs outside the UK.

This activity is funded by an independent medical education grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: 

www.touchRESPIRATORY.com